Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.560
-0.060 (-2.29%)
Aug 14, 2025, 11:32 AM - Market open
Paramount Global Market Cap
Cronos Group has a market cap or net worth of $1.01 billion as of August 14, 2025. Its market cap has increased by 10.28% in one year.
Market Cap
1.01B
Enterprise Value
229.75M
1-Year Change
10.28%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $1.01B, a decrease of -11.53%. That is a compound annual growth rate of -1.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.00B | 29.93% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |